AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tacjas 0.03% Ointment

Prescription Icon
Prescription Required

Marketer

Kiama Lifesciences

Salt Composition

Tacrolimus (0.03% w/w)

Overview Tacjas 0.03% Ointment

Eczema (atopic dermatitis) is treated with Tacjas 0.03% Ointment, which reduces inflammation (skin redness and swelling) by modulating the activity of specific immune cells. This soothes itching and improves atopic dermatitis rashes. Apply Tacjas 0.03% Ointment externally, two to four times daily to affected areas, or as directed by your physician. Gently and evenly spread the ointment until fully absorbed. Avoid overuse and do not bandage or cover treated skin. Report any lack of improvement after two weeks or worsening skin condition. Common side effects may include redness, headache, folliculitis, and application site reactions such as burning, irritation, itching, and redness. Unless medically necessary, this medication is generally not advised during pregnancy or breastfeeding.

Uses of Tacjas 0.03% Ointment

Managing atopic dermatitis

Major Benefits of Tacjas 0.03% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application details. Ensure the affected skin is clean and dry before gently rubbing in the ointment.

Common Side effects of Tacjas 0.03% Ointment:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Tacjas 0.03% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application details prior to use. Ensure the affected skin is clean and dry before gently rubbing in the cream.

How Tacjas 0.03% Ointment works:

Tacjas 0.03% ointment is an anti-inflammatory medication that reduces the activity of immune cells triggering skin inflammation, thereby alleviating itching and improving atopic dermatitis rashes.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tacjas 0.03% Ointment during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Topical Tacjas 0.03% ointment is likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with its use.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No drug interactions identified.

LiverLiverNone

No known drug interactions.

What if you forget to take Tacjas 0.03% Ointment :

Should you forget a dose of Tacjas 0.03% Ointment, apply it immediately. Nevertheless, if your next scheduled application is imminent, omit the missed dose and resume your usual regimen.

Facts to Know About Tacjas 0.03% Ointment

LabelValue
Chemical Classification Macrolide Antibiotics
Developing Habits No.
Treatment Category Cancer Medications
Action Class Calcineurin inhibitor immunosuppressants

FAQs on Tacjas 0.03% Ointment

Tacjas 0.03% Ointment is an immune-modulating medicine that primarily reduces immune system activity. It's indicated for adults with moderate to severe atopic dermatitis (eczema) unresponsive to, or experiencing side effects from, steroid treatments. Atopic dermatitis involves an overactive skin immune response causing inflammation, itch, redness, and dryness. Tacjas 0.03% Ointment targets this abnormal immune response, thereby alleviating inflammation and itching.
Applying Tacjas 0.03% Ointment may cause mild to moderate skin irritation, including burning, itching, redness, warmth, pain, altered sensation, and rash at the application site. These side effects usually subside within a week. Use may also increase the risk of inflamed or infected hair follicles, cold sores, acne, and generalized herpes simplex infections.
Tacjas 0.03% Ointment offers safe and effective short-term atopic dermatitis treatment, demonstrating superior safety compared to other immunosuppressants. Minimal systemic absorption following topical application results in fewer side effects than oral treatments.
Tacjas 0.03% Ointment is not a controlled substance because it lacks abuse potential. Controlled substances require authorization from both a doctor and regulatory authorities due to their potential for misuse.
Prolonged use of Tacjas 0.03% Ointment is associated with a heightened risk of lymphoma, a type of lymph node tumor. Studies indicate a small number of patients using Tacjas 0.03% Ointment or similar medications developed skin cancer or lymphoma. If using Tacjas 0.03% Ointment for over six weeks, or if your eczema worsens or fails to improve, consult your physician.
Tacjas 0.03% Ointment is a non-steroidal medication that modifies the immune system. Primarily used for eczema, particularly atopic dermatitis, it avoids the skin thinning and other side effects associated with steroids.
Tacjas 0.03% Ointment
121
MRP 148
18% off